# A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus Erythematosus

> **NCT07749430** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 13 (estimated)

## Conditions studied

- Refractory Active Systemic Lupus Erythematosus

## Interventions

- **DRUG:** ACG102 Injection

## Key facts

- **NCT ID:** NCT07749430
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2027-01-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749430, "A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus Erythematosus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*